scorecardresearch
Wednesday, August 13, 2025
TopicRanitidine

Topic: ranitidine

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

Ranitidine off essential meds list but India still sells ‘cancer-causing’ antacid shunned by world

Known as Rantac and Zantac in India, ranitidine is still a heartburn go-to. But several countries suspended its sale in 2020 after it was found to contain cancer-causing compound.

Explained: Why India, US haven’t recalled acidity drug Ranitidine but France & Canada have

US expert who flagged the presence of cancer-causing NDMA in Ranitidine says sales must stop permanently.

On Camera

Musk’s golden touch is on the line. Tesla needs him to do what he does best — sell a pen

Tesla sales have been sliding, profits have been shrinking, and brand loyalty is faltering. Elon Musk’s politics has something to do with it.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

India expands Southeast Asia defence footprint with new joint venture in Philippines

Memorandum of understanding between SMPP and ADFC was signed during state visit of Philippines’ President to India earlier this month.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.